Cargando…

466 Bee venom Immunotherapy with Standardized Extract, Two Case Comunication and Clinical Progress

BACKGROUND: Bee venom immunotherapy is a safe and effective treatment, indicated in patients with previous history of severe systemic reactions to bee venom, demonstrating succesful desensitization in more than 90% of cases with standardized extract. Currently in Mexico there is no standardized extr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cardona, Aristoteles Alvarez, Nieto, Leticia Hernandez, Melendez, Alvaro Pedroza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization Journal 2012
Materias:	Abstracts of the XXII World Allergy Congress
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512747/ http://dx.doi.org/10.1097/01.WOX.0000411581.26669.d7

Ejemplares similares

467 Clinical Case. Bee Venom Anaphylaxis
por: Barreto-Sosa, Adriana, et al.
Publicado: (2012)

88 Clinical Features and Diagnostic Value of Specific IGE to Component Allergen in Bee Venom Allergy in Korea
por: Shin, Yoo Seob, et al.
Publicado: (2012)

464 Specific Venom Ige Decrease during 5 Years of Venom Immunotherapy (VIT): Clinical Relevance in Stung and Not Stung Patients
por: Pravettoni, Valerio, et al.
Publicado: (2012)

487 Safety of Sublingual Immunotherapy with Standardized Vaccines of Domestic Mites
por: Alvarez, Mirta, et al.
Publicado: (2012)

92 Serum CTLA-4 AND IL-10 in Hymenoptera Venom Immunotherapy: Equivalence of Different Induction Regimens
por: Riccio, Anna Maria, et al.
Publicado: (2012)

91 Efficacy of Venom Immunotherapy Given Every 3 or 4 Months. A Direct Prospective Comparison With the Conventional Regimen
por: Simioni, Livio, et al.
Publicado: (2012)

468 Urticarial Vasculitis After Bee-sting Therapy
por: Lee, June-Hyuk, et al.
Publicado: (2012)

90 Improving the Diagnosis of Hymenoptera Venom Allergy: Component Resolved Diagnosis
por: Cifuentes, Liliana, et al.
Publicado: (2012)

89 Is Basophil Specific Response to Hymenoptera Venom Related to T Regulatory Cells?
por: Kucera, Petr, et al.
Publicado: (2012)

208 Compliance and Persistence to Grass Immunotherapy Treatment is Comparable for Allergy Immunotherapy Tablets and Subcutaneous Immunotherapy: A Swedish Registry Study
por: Andreasen, Jakob Nørgaard, et al.
Publicado: (2012)

93 Purification of the Allergenic Protein Hyaluronidase From the Venom of Social Wasp Polybia Paulista (Hymenoptera: Vespidae)
por: Justo Jacomini, Débora Laís, et al.
Publicado: (2012)

490 Immunotherapy (IT) Training in Canada: Perspectives of Fellows-in-training on the First Immunotherapy Training Manual
por: Pun, Teresa, et al.
Publicado: (2012)

486 Therapeutic Effect and Security in Asthmatics Adult Patients Treated with Dermatophagoides Pteronyssinus Allergen Sublingual Immunotherapy
por: Rodríguez, José, et al.
Publicado: (2012)

198 AAAAI Survey on Immunotherapy Practice Patterns Concerning Dosing, Dose-Adjustment after Missed Doses and Duration of Immunotherapy
por: Linnemann, Désirée Larenas, et al.
Publicado: (2012)

4 The Risk of Severe Treatment Related Adverse Events is Significantly Lower in Children Compared to Adults When Treated With Standardized Timothy Grass Allergy Immunotherapy Tablets: Post Hoc Analysis of 7 Clinical Trials
por: Andersen, Jens Strodl, et al.
Publicado: (2012)

463 Efficacy of Immunotherapy With Allergenic Extract of Aedes Aegypti in the Treatment of Large Local Reaction to Mosquito Bites in Children
por: Manrique, Maria Amelia, et al.
Publicado: (2012)

60 Tear IFN-G is Increased After Sublingual Immunotherapy in Allergic Conjunctivitis Patients and Correlates With Clinical Improvement
por: Aguilar-Velazquez, Gustavo, et al.
Publicado: (2012)

159 Therapeutic Effect and Safety of the Sublingual Immunotherapy With Tropical House Dust Mite Allergen Vaccines in Asthmatic Cuban Adult Patients
por: Castro Almarales, Raúl Lázaro, et al.
Publicado: (2012)

75 Efficacy of Slow Oral Immunotherapy for Cow's Milk Allergy
por: Ogura, Kiyotake, et al.
Publicado: (2012)

199 Development of a National Guideline on Skin Testing and Immunotherapy
por: Linnemann, Désirée Larenas, et al.
Publicado: (2012)

404 Allergen Specific Immunotherapy as a Treatment for Eosinophilic Esophagitis
por: Perez, Juan Esteban, et al.
Publicado: (2012)

11 Efficacy and Tolerability of HDM Injective Immunotherapy With Monomeric Allergoid
por: Compalati, Enrico, et al.
Publicado: (2012)

489 Does Sublingual Immunotherapy Work with an Immune Deviation Mechanism?
por: Sensi, Laura Giovanna, et al.
Publicado: (2012)

491 Immunotherapy (IT) Training in Canada: Current Experience of Fellows-in-training
por: Pun, Teresa, et al.
Publicado: (2012)

270 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

384 Jessner-kanoff Lymphocytic Infiltrate as a Side Effect of Immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

202 Treatment Satisfaction with Sublingual Immunotherapy in a Real-Life Setting
por: Hadler, Meike, et al.
Publicado: (2012)

200 Efficacy of Mite Sublingual Immunotherapy in 130 Children with Atopic Dermatitis
por: Tang, Jianping
Publicado: (2012)

207 Approach of Paediatric Allergists to Allergen Immunotherapy in Severe Persistent Allergic Rhinitis
por: Fiocchi, Alessandro, et al.
Publicado: (2012)

203 Long-Term Clinical Efficacy of Immunotherapy in Rhino-Conjunctivitis with Pollen Extract
por: Nunes, Carlos, et al.
Publicado: (2012)

488 The Effect of Specific Immunotherapy on the Clinical Response in Patients with Grass-pollen Induced Rhinoconjunctivitis
por: Arsovski, Zoran, et al.
Publicado: (2012)

206 Clinical Effects of Immunotherapy in Patients with Allergic Disease in the National Institute of Respiratory Diseases
por: Gonzalez Galarza, Ma del Rosario, et al.
Publicado: (2012)

105 M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy
por: Diesner, Susanne C., et al.
Publicado: (2012)

397 Standardization and Characterization of Dust Mite Extracts Manufactured in the USA
por: Plunkett, Greg
Publicado: (2012)

156 Economic Evaluation of Grass Tablets for Immunotherapy (oralair) Compared to Placebo in Adults and Children in Italy
por: Cicchetti, Amerigo, et al.
Publicado: (2012)

176 Sublingual Immunotherapy for Grass Pollen Allergy in Children: A Systematic Review and Meta-Analysis
por: Bryson, Rebecca
Publicado: (2012)

72 The Choice of Hypoallergens for Fish and Peach to Develop Food Allergy Specific Immunotherapy (TheFAST Project)
por: Zuidmeer-Jongejan, Laurian, et al.
Publicado: (2012)

160 Candidate for Response Monitoring or Prognostic Biomarkers in Two-Year Sublingual Immunotherapy for Japanese Cedar Pollinosis
por: Fujimura, Takashi, et al.
Publicado: (2012)

205 Allergy Training and Immunotherapy in Latin America: How Survey-Results Lead to a Regional Overview
por: Gomez, R. Maximiliano, et al.
Publicado: (2012)

157 The Post-Treatment Efficacy of House Dust Mite Sublingual Allergen Immunotherapy Tablets in Adults With Allergic Rhinitis
por: Bergmann, Karl-Christian, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3ofipeovtd87rh97nfffubnvku